Tom Petty and the Heartbreakers Beach Party Premiere on Paramount+ in March

Home Depot had a strong fourth quarter, surpassing market expectations. Looking towards the future, they anticipate weaker earnings but higher sales in the 2025 fiscal year, a prediction that has caused a drop in their stock value on the market. On the beverage front, Frozen Shakes served to care facilities have been recalled due to a Listeria outbreak that has resulted in a fatality. Meanwhile, Arbor Realty Trust saw an 11% drop in its stock after reporting a decline in net income for the fourth quarter. In other news, Meta has decided to increase executive bonuses to 200% of salaries, excluding the CEO. Walmart has exceeded expectations in their fourth-quarter results but is projecting a weaker outlook for the future. They also plan to boost their dividend by 13%. Choice Hotels International’s forecast for adjusted earnings per share in the 2025 fiscal year is in line with estimates. A recall was also issued for Naturipe’s Berry Buddies, Berries, and Pancakes Snack Packs as a precautionary measure.

In positive news, Celsius Holdings is set to acquire Alani Nu, expanding their functional lifestyle platform. Stabilus’ Chief Financial Officer, Stefan Bauerreis, is stepping down at the end of the month. On the tech front, Mastercard has launched a Business Builder Program aimed at supporting the creator economy. Similarly, Japanese investors reportedly seek an investment from Tesla in Nissan. Moreover, Nu Holdings Ltd. reported an increase in full-year income. BayWa AG is looking to reduce its stake in BayWa R.e. AG, while EIP plans to increase capital investment. Finally, Fresenius Medical Care is divesting select assets from Spectra Laboratories to Quest Diagnostics as part of a strategic move. Bridge has agreed to go private in a $1.5 billion deal with Apollo, resulting in a surge in their stock prices. Additionally, ReAlpha has acquired GTG to enhance their mortgage operations using an AI-driven real estate platform. Carlyle Group has announced the sale of NSM’s U.S. Commercial Division to New Mountain Capital. Lastly, Medtronic has received FDA approval for the BrainSense Adaptive Deep Brain Stimulation System for Parkinson’s patients, while Crinetics Pharma has appointed Tobin Schilke as their new CFO. OSI Systems secured a $32 million international order for long-range RF systems—exciting developments across various industries.